Aura Biosciences Reports Third Quarter 2025 Financial Results and Business Highlights

GlobeNewswire
2025.11.13 13:08

Aura Provides Phase 3 CoMpass Trial Completion Guidance: 2026 Enrollment Completion and Q4 2027 Topline Data Readout for the 15-Month Primary Endpoint ...